Skip to main content
Top
Published in: Journal of Translational Medicine 1/2024

Open Access 01-12-2024 | Colonoscopy | Research

Gut microbiota dynamics and fecal SCFAs after colonoscopy: accelerating microbiome stabilization by Clostridium butyricum

Authors: Zhenhui Chen, Lu Yu, Jiaxin Liu, Jingjing Kong, Xiaoshi Deng, Xiaotong Guo, Jiamin Shan, Daixuan Zhou, Wendan Li, Yangfan Lin, Wanwen Huang, Weisen Zeng, Xinlong Shi, Yang Bai, Hongying Fan

Published in: Journal of Translational Medicine | Issue 1/2024

Login to get access

Abstract

Background

Colonoscopy is a classic diagnostic method with possible complications including abdominal pain and diarrhoea. In this study, gut microbiota dynamics and related metabolic products during and after colonoscopy were explored to accelerate gut microbiome balance through probiotics.

Methods

The gut microbiota and fecal short-chain fatty acids (SCFAs) were analyzed in four healthy subjects before and after colonoscopy, along with seven individuals supplemented with Clostridium butyricum. We employed 16S rRNA sequencing and GC–MS to investigate these changes. We also conducted bioinformatic analysis to explore the buk gene, encoding butyrate kinase, across C. butyricum strains from the human gut.

Results

The gut microbiota and fecal short-chain fatty acids (SCFAs) of four healthy subjects were recovered on the 7th day after colonoscopy. We found that Clostridium and other bacteria might have efficient butyric acid production through bioinformatic analysis of the buk and assessment of the transcriptional level of the buk. Supplementation of seven healthy subjects with Clostridium butyricum after colonoscopy resulted in a quicker recovery and stabilization of gut microbiota and fecal SCFAs on the third day.

Conclusion

We suggest that supplementation of Clostridium butyricum after colonoscopy should be considered in future routine clinical practice.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hazewinkel Y, Dekker E. Colonoscopy: basic principles and novel techniques. Nat Rev Gastroenterol Hepatol. 2011;8(10):554–64.CrossRefPubMed Hazewinkel Y, Dekker E. Colonoscopy: basic principles and novel techniques. Nat Rev Gastroenterol Hepatol. 2011;8(10):554–64.CrossRefPubMed
3.
go back to reference Rex DK. Optimal bowel preparation–a practical guide for clinicians. Nat Rev Gastroenterol Hepatol. 2014;11(7):419–25.CrossRefPubMed Rex DK. Optimal bowel preparation–a practical guide for clinicians. Nat Rev Gastroenterol Hepatol. 2014;11(7):419–25.CrossRefPubMed
4.
go back to reference Occhipinti KE, Di Palma JA. How to choose the best preparation for colonoscopy. Nat Rev Gastroenterol Hepatol. 2009;6(5):279–86.CrossRefPubMed Occhipinti KE, Di Palma JA. How to choose the best preparation for colonoscopy. Nat Rev Gastroenterol Hepatol. 2009;6(5):279–86.CrossRefPubMed
5.
go back to reference Lee YC, Wang HP, Chiu HM, Lin CP, Huang SP, Lai YP, Wu MS, Chen MF, Lin JT. Factors determining post-colonoscopy abdominal pain: prospective study of screening colonoscopy in 1000 subjects. J Gastroenterol Hepatol. 2006;21(10):1575–80.CrossRefPubMed Lee YC, Wang HP, Chiu HM, Lin CP, Huang SP, Lai YP, Wu MS, Chen MF, Lin JT. Factors determining post-colonoscopy abdominal pain: prospective study of screening colonoscopy in 1000 subjects. J Gastroenterol Hepatol. 2006;21(10):1575–80.CrossRefPubMed
6.
go back to reference Bugajski M, Wieszczy P, Hoff G, Rupinski M, Regula J, Kaminski MF. Modifiable factors associated with patient-reported pain during and after screening colonoscopy. Gut. 2018;67(11):1958–64.CrossRefPubMed Bugajski M, Wieszczy P, Hoff G, Rupinski M, Regula J, Kaminski MF. Modifiable factors associated with patient-reported pain during and after screening colonoscopy. Gut. 2018;67(11):1958–64.CrossRefPubMed
7.
go back to reference Steffenssen MW, Al-Najami I, Baatrup G. Patient-reported minor adverse events after colonoscopy: a systematic review. Acta Oncol. 2019;58(sup1):S22-s28.CrossRefPubMed Steffenssen MW, Al-Najami I, Baatrup G. Patient-reported minor adverse events after colonoscopy: a systematic review. Acta Oncol. 2019;58(sup1):S22-s28.CrossRefPubMed
8.
go back to reference Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol. 2013;16(3):246–54.CrossRefPubMed Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol. 2013;16(3):246–54.CrossRefPubMed
9.
go back to reference Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7(5):563–7.CrossRefPubMed Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7(5):563–7.CrossRefPubMed
10.
go back to reference Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104–19.CrossRefPubMed Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104–19.CrossRefPubMed
11.
go back to reference Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10(7):1775.CrossRefPubMedPubMedCentral Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10(7):1775.CrossRefPubMedPubMedCentral
12.
go back to reference Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–72.CrossRefPubMed Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–72.CrossRefPubMed
13.
go back to reference Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982;83(2):424–9.CrossRefPubMed Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982;83(2):424–9.CrossRefPubMed
14.
go back to reference Wang Q, Al Makishah NH, Li Q, Li Y, Liu W, Sun X, Wen Z, Yang S. Developing clostridia as cell factories for short- and medium-chain ester production. Front Bioeng Biotechnol. 2021;9:661694.CrossRefPubMedPubMedCentral Wang Q, Al Makishah NH, Li Q, Li Y, Liu W, Sun X, Wen Z, Yang S. Developing clostridia as cell factories for short- and medium-chain ester production. Front Bioeng Biotechnol. 2021;9:661694.CrossRefPubMedPubMedCentral
15.
go back to reference Luo H, Yang R, Zhao Y, Wang Z, Liu Z, Huang M, Zeng Q. Recent advances and strategies in process and strain engineering for the production of butyric acid by microbial fermentation. Biores Technol. 2018;253:343–54.CrossRef Luo H, Yang R, Zhao Y, Wang Z, Liu Z, Huang M, Zeng Q. Recent advances and strategies in process and strain engineering for the production of butyric acid by microbial fermentation. Biores Technol. 2018;253:343–54.CrossRef
16.
go back to reference Jiang L, Fu H, Yang HK, Xu W, Wang J, Yang ST. Butyric acid: applications and recent advances in its bioproduction. Biotechnol Adv. 2018;36(8):2101–17.CrossRefPubMed Jiang L, Fu H, Yang HK, Xu W, Wang J, Yang ST. Butyric acid: applications and recent advances in its bioproduction. Biotechnol Adv. 2018;36(8):2101–17.CrossRefPubMed
17.
go back to reference Vital M, Penton CR, Wang Q, Young VB, Antonopoulos DA, Sogin ML, Morrison HG, Raffals L, Chang EB, Huffnagle GB, et al. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome. 2013;1(1):8.CrossRefPubMedPubMedCentral Vital M, Penton CR, Wang Q, Young VB, Antonopoulos DA, Sogin ML, Morrison HG, Raffals L, Chang EB, Huffnagle GB, et al. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome. 2013;1(1):8.CrossRefPubMedPubMedCentral
18.
go back to reference Van den Abbeele P, Belzer C, Goossens M, Kleerebezem M, De Vos WM, Thas O, De Weirdt R, Kerckhof FM, Van de Wiele T. Butyrate-producing clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2013;7(5):949–61.CrossRefPubMed Van den Abbeele P, Belzer C, Goossens M, Kleerebezem M, De Vos WM, Thas O, De Weirdt R, Kerckhof FM, Van de Wiele T. Butyrate-producing clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2013;7(5):949–61.CrossRefPubMed
19.
go back to reference Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, Flint HJ. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol. 2004;186(7):2099–106.CrossRefPubMedPubMedCentral Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, Flint HJ. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol. 2004;186(7):2099–106.CrossRefPubMedPubMedCentral
20.
go back to reference Yoo M, Croux C, Meynial-Salles I, Soucaille P. Metabolic flexibility of a butyrate pathway mutant of clostridium acetobutylicum. Metab Eng. 2017;40:138–47.CrossRefPubMed Yoo M, Croux C, Meynial-Salles I, Soucaille P. Metabolic flexibility of a butyrate pathway mutant of clostridium acetobutylicum. Metab Eng. 2017;40:138–47.CrossRefPubMed
21.
go back to reference Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68(10):5186–90.ADSCrossRefPubMedPubMedCentral Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68(10):5186–90.ADSCrossRefPubMedPubMedCentral
22.
go back to reference Widodo W, Ariani AL, Widianto D, Haltrich D. Genomic comparison of Lactobacillus casei AP and Lactobacillus plantarum DR131 with emphasis on the butyric acid biosynthetic pathways. Microorganisms. 2021;9(2):425.CrossRefPubMedPubMedCentral Widodo W, Ariani AL, Widianto D, Haltrich D. Genomic comparison of Lactobacillus casei AP and Lactobacillus plantarum DR131 with emphasis on the butyric acid biosynthetic pathways. Microorganisms. 2021;9(2):425.CrossRefPubMedPubMedCentral
23.
go back to reference Wu Q, Liu T, Zhu L, Huang H, Jiang L. Insights from the complete genome sequence of Clostridium tyrobutyricum provide a platform for biotechnological and industrial applications. J Ind Microbiol Biotechnol. 2017;44(8):1245–60.CrossRefPubMed Wu Q, Liu T, Zhu L, Huang H, Jiang L. Insights from the complete genome sequence of Clostridium tyrobutyricum provide a platform for biotechnological and industrial applications. J Ind Microbiol Biotechnol. 2017;44(8):1245–60.CrossRefPubMed
24.
go back to reference Chen Z, Chen H, Yu L, Xin H, Kong J, Bai Y, Zeng W, Zhang J, Wu Q, Fan H. Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in helicobacter pylori infection. J Cell Physiol. 2021;236(2):1158–83.CrossRefPubMed Chen Z, Chen H, Yu L, Xin H, Kong J, Bai Y, Zeng W, Zhang J, Wu Q, Fan H. Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in helicobacter pylori infection. J Cell Physiol. 2021;236(2):1158–83.CrossRefPubMed
25.
go back to reference Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–6.CrossRefPubMedPubMedCentral Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–6.CrossRefPubMedPubMedCentral
26.
go back to reference Tong Chen Y-XL, Huang L. ImageGP: an easy-to-use data visulization web server for scientific researchers. IMeta. 2022;1(1):e5.CrossRef Tong Chen Y-XL, Huang L. ImageGP: an easy-to-use data visulization web server for scientific researchers. IMeta. 2022;1(1):e5.CrossRef
27.
go back to reference Zhang S, Wang H, Zhu MJ. A sensitive GC/MS detection method for analyzing microbial metabolites short chain fatty acids in fecal and serum samples. Talanta. 2019;196:249–54.CrossRefPubMed Zhang S, Wang H, Zhu MJ. A sensitive GC/MS detection method for analyzing microbial metabolites short chain fatty acids in fecal and serum samples. Talanta. 2019;196:249–54.CrossRefPubMed
28.
go back to reference Zou Y, Xue W, Luo G, Deng Z, Qin P, Guo R, Sun H, Xia Y, Liang S, Dai Y, et al. 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses. Nat Biotechnol. 2019;37(2):179–85.CrossRefPubMedPubMedCentral Zou Y, Xue W, Luo G, Deng Z, Qin P, Guo R, Sun H, Xia Y, Liang S, Dai Y, et al. 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses. Nat Biotechnol. 2019;37(2):179–85.CrossRefPubMedPubMedCentral
29.
30.
go back to reference Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547–9.CrossRefPubMedPubMedCentral Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547–9.CrossRefPubMedPubMedCentral
31.
go back to reference Letunic I, Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293-w296.CrossRefPubMedPubMedCentral Letunic I, Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293-w296.CrossRefPubMedPubMedCentral
32.
go back to reference Mai V, Greenwald B, Morris JG Jr, Raufman JP, Stine OC. Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota composition. Gut. 2006;55(12):1822–3.CrossRefPubMedPubMedCentral Mai V, Greenwald B, Morris JG Jr, Raufman JP, Stine OC. Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota composition. Gut. 2006;55(12):1822–3.CrossRefPubMedPubMedCentral
33.
go back to reference Jalanka J, Salonen A, Salojärvi J, Ritari J, Immonen O, Marciani L, Gowland P, Hoad C, Garsed K, Lam C, et al. Effects of bowel cleansing on the intestinal microbiota. Gut. 2015;64(10):1562–8.CrossRefPubMed Jalanka J, Salonen A, Salojärvi J, Ritari J, Immonen O, Marciani L, Gowland P, Hoad C, Garsed K, Lam C, et al. Effects of bowel cleansing on the intestinal microbiota. Gut. 2015;64(10):1562–8.CrossRefPubMed
34.
go back to reference Drago L, Toscano M, De Grandi R, Casini V, Pace F. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol. 2016;28(5):532–7.CrossRefPubMed Drago L, Toscano M, De Grandi R, Casini V, Pace F. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol. 2016;28(5):532–7.CrossRefPubMed
35.
go back to reference Deng X, Tian H, Yang R, Han Y, Wei K, Zheng C, Liu Z, Chen T. Oral probiotics alleviate intestinal dysbacteriosis for people receiving bowel preparation. Front Med. 2020;7:73.ADSCrossRef Deng X, Tian H, Yang R, Han Y, Wei K, Zheng C, Liu Z, Chen T. Oral probiotics alleviate intestinal dysbacteriosis for people receiving bowel preparation. Front Med. 2020;7:73.ADSCrossRef
36.
go back to reference D’Souza B, Slack T, Wong SW, Lam F, Muhlmann M, Koestenbauer J, Dark J, Newstead G. Randomized controlled trial of probiotics after colonoscopy. ANZ J Surg. 2017;87(9):E65-e69.CrossRefPubMed D’Souza B, Slack T, Wong SW, Lam F, Muhlmann M, Koestenbauer J, Dark J, Newstead G. Randomized controlled trial of probiotics after colonoscopy. ANZ J Surg. 2017;87(9):E65-e69.CrossRefPubMed
37.
go back to reference Bonavina L, Ariani A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Drago L, Ciprandi G. On digestive disorders ISG: Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation. Acta bio-medica: Atenei Parmensis. 2019;90(7-s):13–7.PubMed Bonavina L, Ariani A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Drago L, Ciprandi G. On digestive disorders ISG: Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation. Acta bio-medica: Atenei Parmensis. 2019;90(7-s):13–7.PubMed
Metadata
Title
Gut microbiota dynamics and fecal SCFAs after colonoscopy: accelerating microbiome stabilization by Clostridium butyricum
Authors
Zhenhui Chen
Lu Yu
Jiaxin Liu
Jingjing Kong
Xiaoshi Deng
Xiaotong Guo
Jiamin Shan
Daixuan Zhou
Wendan Li
Yangfan Lin
Wanwen Huang
Weisen Zeng
Xinlong Shi
Yang Bai
Hongying Fan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2024
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-024-05031-y

Other articles of this Issue 1/2024

Journal of Translational Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.